Large scale control and programming of gene expression using CRISPR.

CRISPR Cell fate control Gene regulatory networks Genotype-to-phenotype mapping High-throughput screening Synthetic biology

Journal

Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332

Informations de publication

Date de publication:
12 2019
Historique:
received: 21 12 2018
accepted: 14 05 2019
pubmed: 11 6 2019
medline: 6 5 2020
entrez: 11 6 2019
Statut: ppublish

Résumé

The control of gene expression in cells and organisms allows to unveil gene to function relationships and to reprogram biological responses. Several systems, such as Zinc fingers, TALE (Transcription activator-like effectors), and siRNAs (small-interfering RNAs), have been exploited to achieve this. However, recent advances in Clustered Regularly Interspaced Short Palindromic Repeats and Cas9 (CRISPR-Cas9) have overshadowed them due to high specificity, compatibility with many different organisms, and design flexibility. In this review we summarize state-of-the art for CRISPR-Cas9 technology for large scale gene perturbation studies, including single gene and multiple genes knock-out, knock-down, knock-up libraries, and their associated screening assays. We feature in particular the combination of these methods with single-cell transcriptomics approaches. Finally, we highlight the application of CRISPR-Cas9 systems in building synthetic circuits that can be interfaced with gene networks to control cellular states.

Identifiants

pubmed: 31181342
pii: S1084-9521(18)30110-1
doi: 10.1016/j.semcdb.2019.05.013
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-132

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Matthew Deyell (M)

Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France.

Sandeep Ameta (S)

Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France.

Philippe Nghe (P)

Laboratoire de Biochimie, CNRS UMR8231, Chimie Biologie Innovation, PSL Research University, ESPCI Paris, 10 Rue Vauquelin, 75005, Paris, France. Electronic address: philippe.nghe@espci.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH